Search Results - Atkan, G

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Abstract OT1-03-19: Design of a phase 1b/2 study to evaluate the efficacy and safety of eribulin mesylate in combination with pembrolizumab in patients with metastatic triple-negative breast cancer

    Abstract OT1-03-19: Design of a phase 1b/2 study to evaluate the efficacy and safety of eribulin mesylate in combination with pembrolizumab in patients with metastatic triple-negat... by Berrak, E, Atkan, G, Song, J, Almonte, A, Karantza, V, Yuan, R

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: